Clinical Trials Logo

Clinical Trial Details — Status: Not yet recruiting

Administrative data

NCT number NCT05592327
Other study ID # PER-ECL-2021-04
Secondary ID
Status Not yet recruiting
Phase N/A
First received
Last updated
Start date November 3, 2022
Est. completion date December 2025

Study information

Verified date October 2022
Source Universitat Internacional de Catalunya
Contact Javi Vilarrasa
Phone 628553000
Email jvilarrasa@uic.es
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The use of dental implants is a predictable procedure to replace the missing tooth with high rates of success and survival. In addition, placing the abutment on the same day as the implant surgery is a safe and biologically sound procedure to minimize bone loss and peri-implant inflammation. Although citric acid antibacterial coating has never been tested in vivo, recent in vitro data support its clinical use due to its antibacterial effect at the abutment level. This prospective randomized controlled clinical trial aims to evaluate the microbiological and inflammatory profile of implant abutments coated with citric acid.


Description:

The study population will consist on patients referred to the Department of Periodontology at Universitat Internacional de Catalunya for the replacement of missing teeth and who meet the following inclusion criteria will be included consecutively in the study. 5.3.1. Inclusion criteria - Patients with ≥18 years old. - Systemically healthy patients. - Patients with healthy periodontal status with a full mouth plaque index ≤ 20% (O'Leary, 1972) and full mouth bleeding index (Ainamo & Bay, 1975) before implant surgery. - Need for at least one dental implant in maxillary and mandibular partially posterior edentulous healed sites. 5.3.2. Exclusion criteria - Patients with some special conditions that could interfere surgical oral procedures. - Patients with non-treated periodontal disease. - Patients with uncontrolled systemic disease that could impair wound healing (i.e. Diabetes Mellitus). - Pregnant women. - Patients allergic to any metallic component of the materials. - Need for bone or soft tissue reconstruction simultaneous to implant placement. - Lack of primary stability during implant placement (i.e., insertion torque < 25 N, ISQ > 60) - Smokers ≥ 10 cigarettes per day. - Patients will be excluded from the study if they violate any of the criteria during the trial, as well as if they desire to withdraw the study or have any adverse reactions to the materials employed. The primary outcome measure will be the reduction of biofilm formation at the test abutments compared with the control abutments at the 12 weeks 6 months, 1 year and 3 year of follow-up. Biofilm formation over abutments will be quantified with Ilumina sequencing analysis.


Recruitment information / eligibility

Status Not yet recruiting
Enrollment 36
Est. completion date December 2025
Est. primary completion date October 2025
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria: - Patients with =18 years old. - Systemically healthy patients. - Patients with healthy periodontal status with a full mouth plaque index = 20% (O'Leary, 1972) and full mouth bleeding index (Ainamo & Bay, 1975) before implant surgery. - Need for at least one dental implant in maxillary and mandibular partially posterior edentulous healed sites. Exclusion Criteria: - Patients with some special conditions that could interfere surgical oral procedures. - Patients with non-treated periodontal disease. - Patients with uncontrolled systemic disease that could impair wound healing (i.e. Diabetes Mellitus). - Pregnant women. - Patients allergic to any metallic component of the materials. - Need for bone or soft tissue reconstruction simultaneous to implant placement. - Lack of primary stability during implant placement (i.e., insertion torque < 25 N, ISQ > 60) - Smokers = 10 cigarettes per day. - Patients will be excluded from the study if they violate any of the criteria during the trial, as well as those that desire to withdraw the study or have any adverse reactions to the materials employed.

Study Design


Related Conditions & MeSH terms


Intervention

Procedure:
Citric acid abutment
The implant surgery will be performed by 3rd year residents of the Postgraduate Program in Periodontology at UIC, supervised by a board-certified periodontist (J.V). Under local anaesthesia, a mid crestal incision will be performed and a full thickness flap will be raised. Implants will be placed following the manufacturer's recommendations. Implant shoulder (IS) will be placed 1 mm subcrestally, and a distance of = 1.5 mm from adjacent natural tooth and = 3 mm between implants will be always respected. Implant stability will be measured with Ostell ISQ. Straight definitive abutments (2 mm height) will be tightened to 25 N respecting the previous randomization procedure. One of the implants will receive an antibacterial- coated abutment (citric acid), while the other implant will receive a non-coated abutment (C). A protector cap will be screwed manually. Implant sites will be sutured with polypropylene 5/0 (Prolene Ethicon, USA) by simple stitches.

Locations

Country Name City State
n/a

Sponsors (2)

Lead Sponsor Collaborator
Universitat Internacional de Catalunya Klockner Implant System

Outcome

Type Measure Description Time frame Safety issue
Primary Biofilm quantification The primary outcome measure will be the reduction of biofilm formation at the test abutments compared with the control abutments at the 12 weeks, 6 months, 1 year and 3 years. Biofilm formation over the retrieved abutments will be quantified by means of Illumina sequencing analysis 12 weeks, 6 months, 1 and 3 years
Secondary Protein expression markers Quantification of protein expressions (IL-10 beta, IL-8 and TNF-beta) for the test and control abutments. This quantification will be performed at 12 weeks, 6 months, 1 and 3 years 12 weeks, 6 months, 1 and 3 years
Secondary Peri-implant disease incidence The incidence of peri-implant disease will be assessed at 1 and 3 years attending to the 2017 World Workshop Classification 1 and 3 years
See also
  Status Clinical Trial Phase
Completed NCT05332327 - Comparison of the Accuracy of Different Periodontal Probes for Peri-implant Pocket Registration
Enrolling by invitation NCT06063876 - Experimental Peri-implant Mucositis on Implant Sites That Were Previously Treated With or Without Implantoplasty N/A
Completed NCT04249024 - Peri-implantitis, Comparing Treatments 970 nm Laser and Mucosal Flap Surgery N/A
Withdrawn NCT03624257 - Comparing Two Treatment Modalities of Peri-implantitis - Blue Laser (445 nm) and Conventional Flap Surgery N/A
Completed NCT03018795 - Ozone Therapy as an Adjunct to the Surgical Treatment of Peri-implantitis N/A
Completed NCT03157193 - Effect of Hyaluronic Acid on Perimplantitis Phase 4
Completed NCT02375750 - Treatment of Peri-implantitis Lesions by Using Biomaterial N/A
Enrolling by invitation NCT02575274 - Peri-Implantitis Surgical Treatment an RCT Study Phase 2/Phase 3
Completed NCT04833569 - ICG-PDT, Periimplantitis, Diabetes Mellitus Phase 1
Not yet recruiting NCT04337645 - Resective Surgical Treatment of Peri-implantitis. N/A
Enrolling by invitation NCT06033859 - Incidence of Bleeding on Probing as an Indicator of Peri-Implant Disease Progression
Active, not recruiting NCT06390124 - Reconstructive Therapy of Peri-implantitis With PDGF-BB (Gem-21) Phase 4
Enrolling by invitation NCT05675241 - Characterizing the Inflammation Around Dental Implants
Recruiting NCT04983758 - 20-year Implant Survival in Periodontally Healthy and Compromised Patients
Completed NCT04874467 - Influence of Keratinized Mucosa on Dental Implants With Mucositis N/A
Not yet recruiting NCT04323540 - Treatment of Peri-implantitis With or Without Simultaneous Soft Tissue Augmentation N/A
Completed NCT04769609 - Reconstructive Surgical Therapy of Peri-implantitis
Completed NCT05724706 - An Evaluation of Salivary Oxidant and Antioxidant Levels in Peri-implant Health and Disease
Completed NCT04559841 - Regenerative Surgical Treatment of Peri-implantitis Using Nanobone With or Without Simvastatin N/A
Recruiting NCT05906810 - Impact of Non-surgical Periodontal Therapy in the Improvement of Early Endothelial Dysfunction in Subjects With Peri-implantitis and Peri-implant Mucositis N/A